Rationalizing Outcome Measures in Dermatologic Surgery

Murad Alam*, Ian A. Maher, Joseph F. Sobanko, Simon S. Yoo, Mathew M. Avram, Hayes B. Gladstone, Andrei Metelitsa, Marian E. Northington, Zakia Rahman, Thuzar M. Shin, Todd V. Cartee

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Dermatologic surgery, including cancer surgery, cosmetic surgery, and laser and energy device procedures, is a well-established branch of dermatology known for minimally invasive, effective, and safe solutions to patient problems. Over time, clinical research pertaining to dermatologic surgery has improved in terms of methodologic rigor, with dermatologic surgery accounting for a large proportion of the comparative effectiveness studies and randomized controlled trials in dermatology. Further improvements in the quality of studies examining dermatologic surgery therapies will require understanding and overcoming several remaining challenges.

Original languageEnglish (US)
Pages (from-to)140-146
Number of pages7
JournalCurrent Dermatology Reports
Issue number3
StatePublished - Oct 1 2015


  • Clinical research
  • Complexity
  • Core outcome measure
  • Cosmetics
  • Dermatologic surgery
  • Funding
  • Laser
  • Measurements
  • Methodology
  • Minimally invasive
  • Outcome
  • Primary outcome measure
  • Quantification
  • Randomized controlled trial
  • Rationalizing
  • Secondary outcome measure
  • Skin cancer surgery
  • Skin surgery
  • Validated

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Rationalizing Outcome Measures in Dermatologic Surgery'. Together they form a unique fingerprint.

Cite this